Seer (NASDAQ:SEER) Issues Quarterly Earnings Results

Seer (NASDAQ:SEER) announced its quarterly earnings results on Tuesday. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.04), FiscalAI reports. The company had revenue of $3.10 million for the quarter, compared to analyst estimates of $3.55 million. Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.

Seer Price Performance

NASDAQ SEER remained flat at $2.16 on Tuesday. 199,128 shares of the company traded hands, compared to its average volume of 644,225. The stock has a market capitalization of $118.76 million, a P/E ratio of -1.74 and a beta of 1.55. The company’s 50-day moving average price is $1.94 and its two-hundred day moving average price is $1.88. Seer has a 12 month low of $1.55 and a 12 month high of $2.41.

Wall Street Analyst Weigh In

SEER has been the topic of a number of recent research reports. TD Cowen upgraded Seer to a “strong-buy” rating in a research note on Monday, April 13th. Canaccord Genuity Group initiated coverage on Seer in a research report on Monday, May 4th. They set a “buy” rating and a $4.00 price target for the company. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $4.00.

Institutional Trading of Seer

A number of institutional investors have recently made changes to their positions in SEER. Bridgeway Capital Management LLC increased its position in shares of Seer by 15.5% during the second quarter. Bridgeway Capital Management LLC now owns 837,443 shares of the company’s stock worth $1,792,000 after purchasing an additional 112,100 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Seer by 16.5% in the 2nd quarter. Geode Capital Management LLC now owns 509,727 shares of the company’s stock valued at $1,091,000 after purchasing an additional 72,265 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Seer by 2.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 235,485 shares of the company’s stock valued at $431,000 after purchasing an additional 6,304 shares in the last quarter. Jane Street Group LLC boosted its stake in Seer by 33.3% during the 1st quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock worth $430,000 after purchasing an additional 63,432 shares during the last quarter. Finally, Susquehanna International Group LLP boosted its stake in Seer by 22.8% during the 3rd quarter. Susquehanna International Group LLP now owns 123,447 shares of the company’s stock worth $268,000 after purchasing an additional 22,918 shares during the last quarter. 75.20% of the stock is owned by institutional investors and hedge funds.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.